Search Results - "Prostatic Neoplasms diagnosis"
-
1
Authors: et al.
Source: Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de ZaragozaSubject Terms: Aged, 80 and over, Male, Persona de Mediana Edad, Anciano, España, Prostatic Neoplasms, Neoplasias de la Próstata, Middle Aged, Estudios Longitudinales, Sistema de Registros, Magnetic Resonance Imaging, Anciano de 80 o más Años, Humanos, Spain, Humans, Aged Aged, 80 and over Humans Longitudinal Studies Magnetic Resonance Imaging Male Middle Aged Prostatic Neoplasms* / diagnosis Prostatic Neoplasms* / epidemiology Prostatic Neoplasms* / mortality Prostatic Neoplasms* / pathology Prostatic Neoplasms* / therapy Registries Spain / epidemiology Watchful Waiting* / statistics & numerical data, Longitudinal Studies, Registries, Espera Vigilante, Watchful Waiting, Masculino, Imagen por Resonancia Magnética, Aged
File Description: application/pdf
-
2
Authors:
Source: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Subject Terms: In der Diskussion, Implementation, Aged [MeSH], Early Detection of Cancer/methods [MeSH], Prostate-Specific Antigen/blood [MeSH], Risk Assessment [MeSH], Humans [MeSH], Prostatic Neoplasms/epidemiology [MeSH], Middle Aged [MeSH], Risk-adapted, Evidence-Based Medicine [MeSH], Mass Screening [MeSH], Implementierung, Male [MeSH], Prostatakarzinom, Germany [MeSH], Risikoadaptation, Prostatic Neoplasms/diagnosis [MeSH], PSA, Screening, Prostate cancer
-
3
Authors: et al.
Source: Br J Gen Pract
Harding, T A, Martin, R M, Merriel, S W, Jones, R, O'Sullivan, J M, Kirby, M, Olajide, O, Norman, A, Bhatt, J, Hulson, O, Martins, T, Gnanapragasam, V J, Aning, J, Burgess, M, Rosario, D J, Pashayan, N, Tesfai, A, Norori, N, Rylance, A & Seggie, A 2024, 'Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus', British Journal of General Practice, vol. 74, no. 745, pp. e534-e543. https://doi.org/10.3399/BJGP.2023.0586
Harding, T A, Martin, R M, Merriel, S WD, Jones, R, O’Sullivan, J M, Kirby, M, Olajide, O, Norman, A, Bhatt, J, Hulson, O, Martins, T, Gnanapragasam, V J, Aning, J, Burgess, M, Rosario, D J, Pashayan, N, Tesfai, A, Norori, N, Rylance, A & Seggie, A 2024, ' Optimising the use of the prostate-specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus ', British Journal of General Practice . https://doi.org/10.3399/BJGP.2023.0586Subject Terms: Male, Consensus, Prostate-Specific Antigen - blood, 03 medical and health sciences, 0302 clinical medicine, prostate-specific antigen, Humans, Mass Screening, Mass Screening - methods, name=SDG 3 - Good Health and Well-being, Early Detection of Cancer, Aged, Prostatic Neoplasms - diagnosis - blood, Primary Health Care, screening, Research, Prostatic Neoplasms, Prostate-Specific Antigen, Middle Aged, prostate cancer, United Kingdom, early detection of cancer, 3. Good health, primary health care, consensus, Practice Guidelines as Topic, Asymptomatic Diseases
File Description: application/pdf
-
4
Authors: et al.
Contributors: et al.
Source: JCO Clinical Cancer Informatics.
Subject Terms: Prostatic Neoplasms/diagnosis, Male, Prostate/pathology, Prostatic Neoplasms, Middle Aged, Clinical Trial, Immunohistochemistry, Artificial Intelligence, Immunohistochemistry/methods, Journal Article, Humans, Prospective Studies, Algorithms, Aged
File Description: application/pdf
-
5
Authors: et al.
Source: Urologie
Die Urologie, 63(7):681-692Subject Terms: Aged, 80 and over [MeSH], Aged [MeSH], Prostatic Neoplasms/pathology [MeSH], Germany/epidemiology [MeSH], Originalien, Male [MeSH], Robot-assisted surgery, Therapieverfahren, Radikale Prostatektomie, Real world data, Tumor register, Roboterassistierte Chirurgie, Adult [MeSH], Humans [MeSH], Prostatic Neoplasms/epidemiology [MeSH], Incidence [MeSH], Middle Aged [MeSH], Krebsregister, Therapeutic procedures, Radical prostatectomy, Real-World-Daten, Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatectomy [MeSH], Prostatic Neoplasms/diagnosis [MeSH], Registries [MeSH]
-
6
Authors: et al.
Contributors: et al.
Source: BMC Med
BMC Medicine, Vol 22, Iss 1, Pp 1-10 (2024)
Lophatananon, A, Muir, K R & Gnanapragasam, V J 2024, 'The efficacy of different biomarkers and endpoints to refine referrals for suspected prostate cancer : the TARGET study (Tiered integrAted tests for eaRly diaGnosis of clinically significant ProstatE Tumours)', BMC Medicine, vol. 22, no. 1, pp. 440. https://doi.org/10.1186/s12916-024-03667-7Subject Terms: Male, Biopsy, Prostate-Specific Antigen/blood, Magnetic Resonance Imaging/methods, PSA, Prostate Health Index (phi), Free Total PSA, Biomarkers, Tumor, Humans, Referral and Consultation, Early Detection of Cancer, Aged, Prostatic Neoplasms/diagnosis, Cambridge Prognostic Groups, Prostate cancer, Research, Prostatic Neoplasms, Early detection, Middle Aged, Prostate-Specific Antigen, PSA density, Magnetic Resonance Imaging, Polygenic risk scores, Biomarkers, Tumor/blood, Tumor/blood, Medicine, Early Detection of Cancer/methods, Biomarkers, MRI
File Description: application/pdf; application/zip; text/xml
Access URL: https://pubmed.ncbi.nlm.nih.gov/39379935
https://doaj.org/article/940d450a9266478ea32be48d83014378
https://www.repository.cam.ac.uk/handle/1810/374363
https://doi.org/10.1186/s12916-024-03667-7
https://doi.org/10.17863/cam.112452
https://www.repository.cam.ac.uk/handle/1810/374792
https://doi.org/10.1186/s12916-024-03667-7 -
7
Authors: et al.
Contributors: et al.
Source: Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Scientific reports, vol. 14, no. 1, pp. 18148
Pavlovic, Blaz; Bräutigam, Konstantin; Dartiguenave, Florence; Martel, Paul; Rakauskas, Arnas; Cesson, Valérie; Veit, Markus; Oechslin, Pascal; Gu, Alexander; Hermanns, Thomas; Saba, Karim; Poyet, Cédric; Hötker, Andreas M; Rupp, Niels J; Valerio, Massimo; Derré, Laurent; Eberli, Daniel; Banzola, Irina (2024). Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy. Scientific Reports, 14(1), p. 18148. Nature Publishing Group 10.1038/s41598-024-68026-1 <http://dx.doi.org/10.1038/s41598-024-68026-1>
Pavlovic, Blaz; Bräutigam, Konstantin; Dartiguenave, Florence; Martel, Paul; Rakauskas, Arnas; Cesson, Valérie; Veit, Markus; Oechslin, Pascal; Gu, Alexander; Hermanns, Thomas; Saba, Karim; Poyet, Cédric; Hötker, Andreas M; Rupp, Niels J; Valerio, Massimo; Derré, Laurent; Eberli, Daniel; Banzola, Irina (2024). Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy. Scientific Reports, 14(18148) Nature Publishing Group 10.1038/s41598-024-68026-1 <http://dx.doi.org/10.1038/s41598-024-68026-1>Subject Terms: Male, Science, Biopsy, 610 Medicine & health, Article, Prostate biopsy, PSA, 10049 Institute of Pathology and Molecular Pathology, Biomarkers, Tumor, Humans, PI-RADS score, Aged, 1000 Multidisciplinary, Prostate cancer, 10042 Clinic for Diagnostic and Interventional Radiology, Prostate, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Prostatic Neoplasms/urine, Prostatic Neoplasms/pathology, Prostatic Neoplasms/diagnosis, Biomarkers, Tumor/urine, Prostate-Specific Antigen/urine, Prostate/pathology, Prostate/diagnostic imaging, Early detection, Non-invasive, Prostate specific antigen, Screening of prostate cancer, Urinary biomarker, mpMRI, 6. Clean water, 3. Good health, 10062 Urological Clinic, 570 Life sciences, biology, Medicine
File Description: application/pdf; ZORA262293.pdf - application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39103428
https://doaj.org/article/b6949f6ccd9044508a54959dcc3ab281
https://serval.unil.ch/notice/serval:BIB_E999C7BB15AD
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E999C7BB15AD0
https://serval.unil.ch/resource/serval:BIB_E999C7BB15AD.P001/REF.pdf
https://boris.unibe.ch/199512/ -
8
Authors: et al.
Source: Bryant, R J, Yamamoto, H, Eddy, B, Kommu, S, Narahari, K, Omer, A, Leslie, T, Catto, J W F, Rosario, D J, Good, D W, Gray, R, Liew, M P C, Lopez, J F, Campbell, T, Reynard, J M, Tuck, S, Barber, V S, Medeghri, N, Davies, L, Parkes, M, Hewitt, A, Landeiro, F, Wolstenholme, J, Macpherson, R, Verrill, C, Marian, I R, Williams, R, Hamdy, F C & Lamb, A D 2023, 'Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique', BJU international, vol. 131, no. 6, pp. 694-704. https://doi.org/10.1111/bju.15978
Subject Terms: Prostatic Neoplasms/diagnosis, Male, Image-Guided Biopsy, Prostate/pathology, Biopsy, Prostate, Prostatic Neoplasms, Magnetic Resonance Imaging, Magnetic Resonance Imaging/methods, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Biopsy/adverse effects, Quality of Life, Humans, Multicenter Studies as Topic, Prospective Studies, Image-Guided Biopsy/adverse effects, Randomized Controlled Trials as Topic
Access URL: https://pubmed.ncbi.nlm.nih.gov/36695816
-
9
Authors: et al.
Source: Biomol Biomed
Biomolecules & Biomedicine, Vol 23, Iss 1 (2023)Subject Terms: Male, 0301 basic medicine, QH301-705.5, Caveolin 1, Prostatic Hyperplasia, Prostatic Neoplasms, prostate cancer, Cell-Free Nucleic Acids / metabolism, Methylation, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, CAV1, Biomarkers / metabolism, cfDNA methylation, Prostatic Neoplasms / diagnosis, biomarker, Humans, Biology (General), Caveolin 1 / genetics, Cell-Free Nucleic Acids, Biomarkers, Research Article
File Description: application/pdf
-
10
Authors: et al.
Source: Revue Médicale Suisse. 19:86-89
Subject Terms: Male, 03 medical and health sciences, Prostatic Hyperplasia / surgery, 0302 clinical medicine, Testicular Neoplasms, Urology, Prostatic Neoplasms / diagnosis, Humans, Urologic Surgical Procedures, Prostatic Hyperplasia / diagnosis, Prostatic Neoplasms / surgery
File Description: application/pdf
-
11
Authors: et al.
Source: Nanoscale Horiz
Neves, M M P S, Richards, S-J, Baker, A N, Walker, M, Georgiou, P G & Gibson, M I 2023, 'Discrimination between protein glycoforms using lectin-functionalised gold nanoparticles as signal enhancers', Nanoscale Horizons, vol. 8, no. 3, pp. 377-382. https://doi.org/10.1039/D2NH00470D
Nanoscale HorizonsSubject Terms: Prostatic Neoplasms/diagnosis, Male, 0301 basic medicine, Glycosylation, Prostate-Specific Antigen/analysis, Metal Nanoparticles, Prostatic Neoplasms, Prostate-Specific Antigen, Antibodies, Chemistry, 03 medical and health sciences, Lectins, Lectins/metabolism, Humans, Gold
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/36651292
https://pure.manchester.ac.uk/ws/files/279501142/Final.pdf
https://doi.org/10.1039/D2NH00470D
https://research.manchester.ac.uk/en/publications/8b136627-697e-4222-bc41-3356e9e7ea92
https://www.mendeley.com/catalogue/3a6042c1-0313-3d5c-930d-692ebfb51be4/
http://www.scopus.com/inward/record.url?scp=85148964015&partnerID=8YFLogxK -
12
Authors: et al.
Source: Clinica Chimica Acta. 537:127-132
Subject Terms: NcRNA, Male, 0301 basic medicine, Exosomes - genetics, RNA, Untranslated, Tumor - genetics, Exosomes, 03 medical and health sciences, Diagnosis, Prostatic Neoplasms - diagnosis - genetics, Biomarkers, Tumor, Humans, 0303 health sciences, Prostate cancer, Untranslated, Prostatic Neoplasms, Biomarker, name=SDG 3 - Good Health and Well-being, 3. Good health, Exosome, MicroRNAs, RNA, Long Noncoding, RNA, Long Noncoding, Biomarkers
Access URL: https://pubmed.ncbi.nlm.nih.gov/36330945
-
13
Authors: et al.
Contributors: et al.
Source: Modern Pathology. 35:1449-1457
Subject Terms: Male, Observer Variation, Biopsy, Prostatic Neoplasms, Prostatic Neoplasms* / diagnosis, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Artificial Intelligence, Large-Core Needle, Humans, Biopsy, Large-Core Needle, Neoplasm Grading, Prostatic Neoplasms* / pathology
Access URL: https://pubmed.ncbi.nlm.nih.gov/35487950
-
14
Authors: et al.
Source: World J Urol
Subject Terms: Male, Aged, 80 and over, Adult, Image-Guided Biopsy, Prostatic Neoplasms, Middle Aged, Risk Assessment, ddc, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Original Article, Prostate cancer, mpMRI, Prostate biopsy, Risk models, Humans, Aged, 80 and over [MeSH], Aged [MeSH], Risk Assessment [MeSH], Adult [MeSH], Humans [MeSH], Image-Guided Biopsy [MeSH], Predictive Value of Tests [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Hospitals, High-Volume [MeSH], Male [MeSH], Prostatic Neoplasms/diagnosis [MeSH], Multiparametric Magnetic Resonance Imaging [MeSH], Multiparametric Magnetic Resonance Imaging, Hospitals, High-Volume, Aged, Retrospective Studies
File Description: application/pdf
-
15
Authors: et al.
Source: Appl Health Econ Health Policy
Risør, B W, Tayyari Dehbarez, N, Fredsøe, J, Sørensen, K D & Pedersen, B G 2022, 'Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway : A Decision Tree Approach', Applied Health Economics and Health Policy, vol. 20, no. 6, pp. 867-880. https://doi.org/10.1007/s40258-022-00741-0
Risør, B W, Tayyari Dehbarez, N, Fredsøe, J H, Sørensen, K D & Pedersen, B G 2022, 'Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway : A Decision Tree Approach', Applied Health Economics and Health Policy, vol. 20, no. 6, pp. 867-880. https://doi.org/10.1007/s40258-022-00741-0Subject Terms: Prostatic Neoplasms/diagnosis, Male, Hematologic Tests, Cost-Benefit Analysis, Decision Trees, Prostatic Neoplasms, Prostate-Specific Antigen, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Humans, Original Research Article, Quality-Adjusted Life Years
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/35934771
https://vbn.aau.dk/da/publications/bf130e2e-07d7-4e90-8f2e-60754a6772b5
https://vbn.aau.dk/ws/files/495934763/s40258_022_00741_0.pdf
https://doi.org/10.1007/s40258-022-00741-0
http://www.scopus.com/inward/record.url?scp=85135579702&partnerID=8YFLogxK
https://pure.au.dk/ws/files/331566600/s40258_022_00741_0.pdf
https://pure.au.dk/ws/files/331566600/s40258_022_00741_0.pdf
https://doi.org/10.1007/s40258-022-00741-0
https://pure.au.dk/portal/en/publications/1bcb03dd-85a2-4407-a1b7-96eccffd1437 -
16
Authors: et al.
Source: Larsen, S B, Dehlendorff, C, Skriver, C, Pottegård, A, Friis, S, Røder, M A, Brasso, K & Duun-Henriksen, A K 2022, ' Prescription rates for commonly used drugs before and after a prostate cancer diagnosis ', Cancer Causes and Control, vol. 33, pp. 417–428 . https://doi.org/10.1007/s10552-021-01537-8
Larsen, S B, Dehlendorff, C, Skriver, C, Pottegård, A, Friis, S, Røder, M A, Brasso, K & Duun-Henriksen, A K 2022, ' Prescription rates for commonly used drugs before and after a prostate cancer diagnosis ', Cancer Causes and Control, vol. 33, no. 3, pp. 417-428 . https://doi.org/10.1007/s10552-021-01537-8Subject Terms: Prostatic Neoplasms/diagnosis, Aged, 80 and over, Male, Prostate cancer, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Prostatic Neoplasms, Lag-time, Middle Aged, 3. Good health, 03 medical and health sciences, Surveillance bias, Prescriptions, 0302 clinical medicine, Pharmaceutical Preparations, 80 and over, Humans, Drug use, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Prescription rate, Aged
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/35006514
https://curis.ku.dk/ws/files/378165627/Prescription_rates_for_commonly_used_drugs_preprint.pdf
https://portal.findresearcher.sdu.dk/da/publications/88a1a039-57ab-424c-acd3-31668eceb039
https://doi.org/10.1007/s10552-021-01537-8
https://portal.findresearcher.sdu.dk/da/publications/88a1a039-57ab-424c-acd3-31668eceb039 -
17
Authors: et al.
Contributors: et al.
Source: EISSN: 1929-0748 ; JMIR Research Protocols ; https://hal.science/hal-04888757 ; JMIR Research Protocols, 2024, 13, pp.e63551. ⟨10.2196/63551⟩ ; https://www.researchprotocols.org/2024/1/e63551
Subject Terms: PSA, liquid biopsy, urinary exosome, diagnosis, prostate-specific antigen, prostate cancer, liquid biopsy urinary exosome diagnosis PSA prostate-specific antigen prostate cancer, MESH: Biomarkers, Tumor / urine, MESH: Case-Control Studies, MESH: Exosomes* / metabolism, MESH: Humans, MESH: Male, MESH: Prostate-Specific Antigen* / blood, MESH: Prostatic Neoplasms* / diagnosis, MESH: Prostatic Neoplasms* / urine, [SDV]Life Sciences [q-bio]
Relation: info:eu-repo/semantics/altIdentifier/pmid/39024018; PUBMED: 39024018; WOS: 001317376300001
-
18
Authors: et al.
Source: Birkeland, S, Bismark, M, Barry, M J & Möller, S 2024, 'Associations between knowledge of health issues and health care satisfaction and propensity to complain : a cross-sectional survey of adult men in Denmark', BMJ Open, vol. 14, no. 5, e076257. https://doi.org/10.1136/bmjopen-2023-076257
Subject Terms: Decision Making, ETHICS (see Medical Ethics), GENERAL MEDICINE (see Internal Medicine), Health Education, MEDICAL LAW, Quality in health care, Cross-Sectional Studies, Humans, Middle Aged, Patient Participation, Male, Health Knowledge, Attitudes, Practice, Patient Satisfaction, Prostate-Specific Antigen/blood, Prostatic Neoplasms/diagnosis, Denmark, Surveys and Questionnaires, Aged
File Description: application/pdf
-
19
Authors: et al.
Source: BMC Res Notes
BMC Research Notes, Vol 16, Iss 1, Pp 1-6 (2023)Subject Terms: Prostatic Neoplasms/diagnosis, Male, Prostate cancer, Science (General), Survival, QH301-705.5, Denmark, Trajectory, Prostatic Neoplasms, Denmark/epidemiology, 3. Good health, Q1-390, Research Note, Artificial Intelligence, Clinical data, Medicine, Humans, Biology (General), Early Detection of Cancer, Retrospective Studies
-
20
Authors: et al.
Contributors: et al.
Source: Lancet Oncol
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
LANCET ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
instname
Bancroft, EK, Page, EC, Brook, MN, Thomas, S, Taylor, N, Pope, J, McHugh, J, Jones, AB, Karlsson, Q, Merson, S, Ong, KR, Hoffman, J, Huber, C, Maehle, L, Eeles, RA & Evans, D G 2021, 'A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.', The Lancet. Oncology, vol. 22, no. 11, pp. 1618-1631. https://doi.org/10.1016/S1470-2045(21)00522-2Subject Terms: Adult, Male, Heterozygote, Prostate-Specific Antigen/blood, DNA Mismatch Repair/*genetics, MUTATION CARRIERS, DNA Mismatch Repair/genetics, DNA Mismatch Repair, FAMILIES, SDG 3 - Good Health and Well-being, Biomarkers, Tumor, Humans, Prospective Studies, Prostatic Neoplasms/*diagnosis/epidemiology/genetics, EXTRACOLONIC CANCERS, Early Detection of Cancer, Germ-Line Mutation, Aged, Prostatic Neoplasms/diagnosis, SPECTRUM, Science & Technology, MORTALITY, Incidence, LYNCH SYNDROME, Prostatic Neoplasms, Articles, Middle Aged, Prostate-Specific Antigen, RISKS, PREVALENCE, 3. Good health, DNA-Binding Proteins, MutS Homolog 2 Protein, Oncology, Biomarkers, Tumor/blood, Tumor/blood, IMPACT Study Collaborators, Life Sciences & Biomedicine, Biomarkers, DNA-Binding Proteins/genetics, MutS Homolog 2 Protein/genetics
File Description: application/pdf; text; Print-Electronic
Access URL: http://www.thelancet.com/article/S1470204521005222/pdf
https://pubmed.ncbi.nlm.nih.gov/34678156
https://ddd.uab.cat/record/250487
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5289
https://openaccess.sgul.ac.uk/id/eprint/113967/1/1-s2.0-S1470204521005222-main.pdf
https://www.sciencedirect.com/science/article/pii/S1470204521005222
https://www.ncbi.nlm.nih.gov/pubmed/34678156
http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00522-2/fulltext
https://pubmed.ncbi.nlm.nih.gov/34678156/
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00522-2/fulltext
https://findanexpert.unimelb.edu.au/scholarlywork/1602413-a-prospective-prostate-cancer-screening-programme-for-men-with-pathogenic-variants-in-mismatch-repair-genes-%28impact%29--initial-results-from-an-international-prospective-study.
https://discovery-pp.ucl.ac.uk/id/eprint/10152450/
https://eprints.soton.ac.uk/456776/
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science